Monitor Closely (1)pentobarbital will lower the extent or outcome of fentanyl transdermal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Intently. Coadministration of fentanyl with CYP3A4 inducers could lead on to the lower in fentanyl plasma concentrations, lack of efficacy or, possibly, enhancement of a withdrawal syndrome inside a affected https://bradk900rgu8.blogmazing.com/profile